MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); S. 3822, Break Up Big Medicine Act; Issues related to support for independent physician practices, community pharmacies, and community-based care; Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA C BABB | — |
| SHANA BEAVIN New | Prof. Staff Member, House Energy & Commerce Committee Minority Staff; Program Analyst, Centers for Disease Control and Prevention; Leg. Dir., Rep. Jim Matheson. |
| BRIAN BRANTON | Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink |
| RICHARD BUCKLEY | — |
| DIANA FELNER | — |
| BEN JONES | — |
| JOHN RICHARDSON | — |
Medicare/Medicaid MMM
H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA C BABB | — |
| SHANA BEAVIN New | Prof. Staff Member, House Energy & Commerce Committee Minority Staff; Program Analyst, Centers for Disease Control and Prevention; Leg. Dir., Rep. Jim Matheson. |
| BRIAN BRANTON | Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink |
| DIANA FELNER | — |
| BEN JONES | — |
| JOHN RICHARDSON | — |
| MATTHEW WILLIAMS | — |
Pharmacy PHA
H.R. 3164, Ensuring Community Access to Pharmacist Services Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA C BABB | — |
| BRIAN BRANTON | Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink |
| RICHARD BUCKLEY | — |
| DIANA FELNER | — |
Manufacturing MAN
H.R. 2444, Promoting Resilient Supply Chains Act; S.257, Promoting Resilient Supply Chains.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA C BABB | — |
| BRIAN BRANTON | Chief of Staff, Congressman Polis; Chief of Staff, Congressman Sestak; Legislative Director, Congressman Wu; Legislative Counsel, Congressman Holt; Legislative Assistant, Congresswoman Mink |
| RICHARD BUCKLEY | — |
| DIANA FELNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.